Navigation Links
BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update
Date:2/4/2010

ase 2 study for forodesine in the treatment of cutaneous T-cell lymphoma (CTCL) achieved its protocol-specified objective of enrolling 100 late-stage patients (Stage IIB to IVA).  The Company expects to report data from the study in the second half of 2010.
  • The Phase 2 single-arm, open-label study evaluating 200 mg of forodesine twice-daily in patients with chronic lymphocytic leukemia (CLL) is beyond half way to its enrollment target of 26 patients and is ongoing.

BCX4208 Program

  • During the fourth quarter 2009, BioCryst began enrolling a randomized, double-blind, placebo-controlled Phase 2 study to evaluate the efficacy and safety of BCX4208 in subjects with gout.  The study's primary objective is to determine the effect of different doses of orally administered BCX4208 on serum uric acid levels in patients with gout.  Results from the first part of this study are expected in the second quarter of 2010.  

  • BioCryst is evaluating alternatives for an additional blinded study to evaluate the efficacy and safety of BCX4208 as an add-on treatment with another urate-lowering treatment for gout that has a different mechanism of action.

Conference Call and Web Cast

BioCryst's management team will host a conference call and Web cast on Thursday, February 4, 2010 at 11:00 a.m. Eastern Time to discuss these financial results and recent corporate developments.  To participate in the conference call, please dial 1-888-206-4913 (United States) or 1-913-312-9315 (International).  No passcode is needed for the call.  The Web cast can be accessed by logging onto

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. BioCrysts Partner Shionogi Launches Peramivir In Japan Under The Name RAPIACTA
2. BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors
3. BioCryst Announces Pricing of Public Offering of Common Stock
4. BioCryst to Present at Oppenheimer Healthcare Conference
5. Emergency Use Authorization Granted For BioCrysts Peramivir
6. BioCryst to Present at JMP Securities Healthcare Conference
7. BioCryst Clarifies Government Declaration Regarding Peramivir
8. BioCryst Provides Update Regarding Peramivir for Influenza
9. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
10. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
11. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... YORK and PLAINSBORO, N.J. ... announced today its support of the National Hemophilia ... Care , which provides support to people with ... physical and psychosocial challenges that can impede disease ... six modules, Communication With Your Provider About ...
(Date:9/18/2014)... 18, 2014 After 6 months of ... finally here - the new programme for the next Cool ... of our global Cool Chain series, has just been released! ... As the lines between supply chain, logistics, QA ... programme that is broad and yet specific, focused and yet ...
(Date:9/18/2014)... 18, 2014   Regulus Therapeutics Inc . ... leading the discovery and development of innovative medicines ... ATHENA natural history of disease study in patients ... with no approved therapy. The ATHENA study is ... function markers such as Glomerular Filtration Rate ("GFR"), ...
Breaking Medicine Technology:Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 2Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 3Europe's Biggest and Longest-Running Gathering of Life Sciences Logistics, Supply Chain & QA Professionals 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6
... March 31, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... is initiating launch activities of Nulecit™ (sodium ferric ... of GeneraMedix Inc.,s, Abbreviated New Drug Application (ANDA). ... alternative to Sanofi-Aventis, Ferrlecit ® .  In July ...
... DIEGO, March 31, 2011 OncoSec Medical Inc. (OTC BB: ... tumor cancers, announced today that it has raised more than ... to three institutional investors. OncoSec issued 1,456,000 units at a ... Each unit consisted of one share of common stock and ...
Cached Medicine Technology:Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia 2Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia 3Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia 4OncoSec Medical Closes $1.1M Financing 2
(Date:9/18/2014)... This news release is available in German . ... at Technische Universitt Mnchen have won the ,International ... Hepatitis C Virus., As their prize, the scientists will ... the space station. The project involves crystallizing two proteins ... shuttle bringing these proteins to the International Space Station ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 According to a ... and Services Market - Global Industry Analysis, Size, Share, Growth, ... and services market was valued at USD 77607.7 million in ... 5.9% from 2014 to 2020, to reach an estimated value ... products and services market is growing at a rapid pace ...
(Date:9/18/2014)... September 18, 2014 “Awesome” is the ... (Smart Teens Accepting Responsibility Today) Internship Program at ARDX ... Darcy C. describe the program as “Inspirational” and “Life-changing,” ... idea about what they would be doing during their ... do food runs and other mindless tasks,” but, instead ...
(Date:9/18/2014)... Maureen Salamon HealthDay Reporter ... in midlife may be associated with increased odds of ... years, new research suggests. The study, which did ... conditions, also suggested that the migraine-Parkinson,s association was stronger ... is a warning sign of a pending attack that ...
(Date:9/18/2014)... How much is a serving? , ... contributing to the obesity epidemic in the United States. ... how to manage portion size during the next “Healthy ... Humility House, 755 Ohltown Road, Austintown. , Registered dietician ... discussion and answer questions from 12:30 to 2 p.m. ...
Breaking Medicine News(10 mins):Health News:Hepatitis C virus proteins in space 2Health News:Dialysis Products and Services Market Expected to Reach USD 115.4 Billion Globally in 2020 2Health News:Dialysis Products and Services Market Expected to Reach USD 115.4 Billion Globally in 2020 3Health News:Dialysis Products and Services Market Expected to Reach USD 115.4 Billion Globally in 2020 4Health News:ARDX Internship Helps Students to START on the Right Business Path 2Health News:ARDX Internship Helps Students to START on the Right Business Path 3Health News:ARDX Internship Helps Students to START on the Right Business Path 4Health News:Are Migraines in Middle Age Tied to Raised Parkinson's Risk Later? 2Health News:Are Migraines in Middle Age Tied to Raised Parkinson's Risk Later? 3Health News:HMHP Workshop Addresses Portion Control 2
... newsletter deals with two pressing societal concerns the ... perspective of older minority adults. WHAT,S HOT is ... (GSA), the country,s largest interdisciplinary organization devoted to the ... by sanofi-aventis. Based on presentation highlights from GSA,s ...
... puzzle, because less visceral fat should mean less obesity-linked ... -- Blacks tend to carry around less of a ... though they suffer more from obesity-linked illness, researchers report. ... guidelines may need to be tailored to specific racial ...
... , , SAN DIEGO, Dec. 18 I AM ... an event to bring peace and wellness to children and their ... suffer from illnesses such as asthma, diabetes and cancer, as well ... stress and pain. This will be an inspiring and eye-opening event ...
... University of Vigo, Rutgers University in the United States ... developed "laser spinning", a novel method of producing glass ... bioglass nanofibres, the bioactive glass used in regenerating bone, ... possible to produce glass nanofibres of compositions that would ...
... , ... an inescapable part of modern life. According to Patt Lind-Kyle, the key to thriving (instead ... instead of allowing it to manage you. , ... Fulton, CA (PRWEB) December 18, 2009 -- Stress and worry consume many ...
... Local ... ... 2009 -- Milton & DeKruif, a Glendale - based law firm serving the needs of ... development campaign in order to raise its market visibility in front of new and existing ...
Cached Medicine News:Health News:Blacks Have Less 'Bad Fat' Than Whites 2Health News:Blacks Have Less 'Bad Fat' Than Whites 3Health News:Blacks Have Less 'Bad Fat' Than Whites 4Health News:Kids Discover Their Magic for Helping Patients and Families 2Health News:Dancing in the Eye of the Hurricane: How to Stop Running from Stress…and Start Asking It to Dance 2Health News:Dancing in the Eye of the Hurricane: How to Stop Running from Stress…and Start Asking It to Dance 3Health News:Dancing in the Eye of the Hurricane: How to Stop Running from Stress…and Start Asking It to Dance 4Health News:Milton & DeKruif Launches New Client Development Campaign 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: